Status:
TERMINATED
Heart Failure and Peritoneal Ultrafiltration
Lead Sponsor:
Vantive Health LLC
Collaborating Sponsors:
Baxter Healthcare Corporation (Former Sponsor)
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The objective of the study is to determine if the addition of peritoneal ultrafiltration to standard therapy in treatment-resistant severe heart failure patients will improve fluid balance and functio...
Eligibility Criteria
Inclusion
- Adults with congestive heart failure (CHF) who remain fluid overloaded despite standard treatment.
Exclusion
- Patients who have reversible CHF or have diseases or conditions that would contraindicate the use of peritoneal dialysis.
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00368641
Start Date
August 1 2006
End Date
April 1 2008
Last Update
July 15 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
San Jose, California, United States
2
Torrance, California, United States
3
Denver, Colorado, United States
4
Evanston, Illinois, United States